4.4 Article

Renal Function After Hematopoietic Stem Cell Transplantation in Children

期刊

PEDIATRIC BLOOD & CANCER
卷 53, 期 2, 页码 197-202

出版社

WILEY
DOI: 10.1002/pbc.22030

关键词

glomerulopathy; hematopoietic stem cell transplantation; tubulopathy

资金

  1. Turkish Society of Nephrology
  2. Scientific Research Fund of the Akdeniz University

向作者/读者索取更多资源

Objectives. The aim Of this study was to assess glomerular and tubular renal function after HSCT in children in a prospective trial. Methods. Renal function was assessed prospectively before HSCT (on day -10), oil clays +30, +100, and at least 6 months after transplantation in 34 patients (2 1 females/13 males) with a mean age of 8.2 years. The following parameters were investigated: glomerular filtration rate (GFR) by creatinine clearance (CrCl), cystatin C (CysC)-based formula and plasma clearance of radiolabeled diethylenetriaminepentaacetic acid (Tc-99m-DTPA), urinary excretion of beta(2)-microglobulin (beta M-2), beta-N-acetylglucosaminidase (beta-NAG), fractional excretion Of sodium (FENa) and fractional tubular phosphate reabsorption (TP/CrCl). Results. Nine patients (26.4%) suffered from acute renal insufficiency within the first 100 clays after transplantation. All patients who developed acute renal insufficiency were treated successfully Without renal replacement therapy. Age sex, primary diagnosis, sepsis, veno-occlusive disease, acute graft versus host disease, and use of vancomycin were not significant risk factors for the development of acute renal in insufficiency. the medians Tc-99m-DTPA-based GFR of patients after HSCT showed a statistically significant decrease when compared with pre-transplant values. beta-NAG excretion was significantly elevated in the first 30 clays after HSCT. Conclusion. Acute and chronic renal impairment can be developed in patients Who undergo HSCT even though the pre-transplant renal function is in normal limits and file conditioning regimen does not include TBI. Both glomerular and tubular renal function evaluation should be part of a long-term follow-up in children following HSCT. Pediatr Blood Cancer 2009;53:197-202. (C) 2009 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据